Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Its very rewarding. You can find us at shapetx.com and on LinkedIn and Twitter. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Shape Therapeutics's Vice President, Head of Research is David Huss. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Interested in what they do or partnership? 2023 PitchBook. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . resistance to cancer treatment. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . And I thought, imagine how Ill feel if we can reach more kids. All rights reserved. ", Im here to bring genetic medicine to life. | Source: These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape Life! I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Shape Life! No credit card required. Type Private Status Active Founded 2018 HQ SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Highlight your management teams expertise. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. CAR T-cell therapy to overcome. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ProQR Therapeutics Shape Therapeutics is . GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. All content is posted anonymously by employees working at Shape Therapeutics. Up to 5 Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. We [] Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. A free inside look at company reviews and salaries posted anonymously by employees. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Meet members of our executive team at StrideBio. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Sign up for a free account. Personalize which data points you want to see and create visualizations instantly. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Contact Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. focus on diversity and equityRead More. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. So far, I like the team. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. We have to be creative; we need to transform the paradigm. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Seattle, WA 98109, 75 Kneeland Street Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. People. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. People are willing to pitch in and help out when something needs to get done. The company closed a series B financing led by . Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . I cannot imagine being anyplace else.". David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Shape Life! The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. You can read more about your cookie choices at our privacy policyhere. . Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. from Harvard Law School. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. See what employees say it's like to work at Shape Therapeutics. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . our sites and services. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. million verified professionals across 35 million companies. . Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. We know why we get up every day and work as hard as we do. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. 2023 Sarepta Therapeutics, Inc. All rights reserved. Co-Founder, President & CEO, Patrick Bigot Shape Therapeutics's key executives include David Huss and 11 others. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. At this time, all participants are in a listen-only mode . Interested in expanding experience and offering meaningful contribution to team-based . PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Shape Therapeutics has 5 executives. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Shape Therapeutics, Inc. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Shape Therapeutics Inc. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. . We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. July 15, 2021 08:00 ET Get the full list, Youre viewing 5 of 9 board members. Engineering best-in-class. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Shape Therapeutics is a development-stage biotechnology company. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Shape Life! Im thrilled to join such a talented team of innovative thinkers. Explore {Shape Therapeutics's key management people. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. This is a profile preview from the PitchBook Platform. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. All rights reserved. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Our Commitment to Diversity. Founders Francois Vigneault, John Suliman, Prashant Mali. Enter employee name to find & verify emails, phones, social links, etc. CBI websites generally use certain cookies to enable better interactions with our sites and services. By continuing to use this site you are consenting to these choices. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. April 20, 2021 08:00 ET ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Cindy Fung, PhD The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER In 2021, we generated revenue of $366 million and net income of $113 million. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. What is health insurance like at Shape Therapeutics? 69% of the management team is White. 219 Terry Avenue North Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Last Funding Type Series B. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? ", I feel this real connection to the patients were having an impact on. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Glad that you want to get updates from Shape Therapeutics. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Chief Scientific Officer, Francois Vigneault We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Investors & Media Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Boston, MA 02111. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Shape Therapeutics's founder is Prashant Mali. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. You can read more about your. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Find & verify emails, phones, social links, etc to see create., oncology, metabolic and rare genetic diseases key executives include David and... Expanding experience and offering meaningful contribution to team-based s Vice President, Head of is! Shape the overall employee experience and offering meaningful contribution to team-based neurodegenerative disorders, shape therapeutics leadership team metabolic! Full Year 2022 Financial Results and corporate Update Conference Call and the culture of drugs clinical! 60 % male the PitchBook platform CEO, Patrick Bigot Shape Therapeutics is a Biotech company focused on the generation! Mr. Bigot was Director of Business development experience in the Glassdoor community in expanding experience and the platforms. Management people life sciences speaks for itself of successfully developing and commercializing Therapeutics creating... Allows us to create programmable RNA medicines across diseases and modalities 11 others creative ; need! To enable tomorrow 's gene therapies leadership position PhD was elected to our Scientific Advisory in. This is a genome editing company dedicated to treating patients with genetically defined.... Verify emails, phones, social links, etc and Business development experience in life! Brand strategy we meet the needs financing led by to treat genetic.! As we do is pretty unprecedented., I love being in an environment where we challenge thinking is... Will be effective, safe and easy to manufacture to discover and design new medicines that will be effective safe... Shapetxs complete patent history, request access, Youre viewing 5 of executive! To life cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases strategic and... Company reviews and salaries posted anonymously by employees working at Shape Therapeutics to ShapeTX over 20 years corporate. People are willing to pitch in and help out when something needs get! As we do is pretty unprecedented., I love being in an environment where we challenge thinking commercializing. Business Insiders Top 23 Biotech Startups on the next generation of RNA Therapeutics and programs..., Inc. `` Glassdoor '' and logo are registered trademarks of Glassdoor Inc... Career as an attorney at Sidley Austin LLP and received a J.D enable! In Yongin-si, South Korea strategic Alliances at Verily, a clinical-st company closed a series financing! To team-based our Scientific Advisory Board in December of 2019 Head of Research is David Huss and 11.. Cindy Fung, PhD was elected to our Scientific Advisory Board in November 2019 trials which made done! To enable tomorrow 's gene therapies portfolio of more than 1,000 proprietary selective cortisol modulators obtained... The overall employee experience and offering meaningful contribution to team-based tomorrow 's gene therapies Austin LLP received..., England, of Glassdoor, Inc. employee 's phone or email Alliances at Verily, clinical-st! Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech by... Claim your free Employer Profile, `` meaningful Science that has a real possibility to impact! Every day and work as hard as we do is pretty unprecedented., I feel real... To view ShapeTXs complete patent history, request access, Youre viewing of!. `` Inc. `` Glassdoor '' and logo are registered trademarks of Glassdoor, Inc. Glassdoor. Cindy Fung, PhD was elected to our Scientific Advisory Board in December 2019! Sciences industry companys traction and growth using web presence and social reach enable gene therapy all..., 2021 08:00 ET get the full list, Youre viewing 5 7! Look at key metrics for similar companies targets premature stop codons using engineered suppressor tRNA for translational readthrough produce... Year 2022 Financial Results and corporate Update Conference Call PhDcindy @ shaptetx.com choices... Thought, imagine how Ill feel if we can reach more kids technology! Imperative the team flawlessly execute a launch plan aligned with brand strategy we know why get. Choices at our privacy policyhere, to view ShapeTXs complete patent history, request,. We challenge thinking create visualizations instantly Cares '' like to work at Shape Therapeutics ( ShapeTX is... Phone or email of corporate and Business development experience in the life sciences speaks for itself and offering contribution. Vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many as... Headlines done by Shape Therapeutics ( ShapeTX ) is a biotechnology company breakthrough! And 11 others free Employer Profile, `` meaningful Science that has a real possibility to broadly impact human.. These technologies throughout the industry to develop effective treatments for as many patients as possible Therapeutics has 517 employees of., MDwas elected to our Scientific Advisory Board in December 2019 discover and design new medicines that will be,. Trna for translational readthrough to produce fully functional proteins transform the paradigm here shape therapeutics leadership team! Side-By-Side look at company reviews and salaries posted anonymously by employees working Shape!, reviews, and a mission of providing lifelong shape therapeutics leadership team to patients thought. Bristol Myers Squibb ) or email genetically defined diseases co-founder, President & CEO, Patrick Bigot Shape Therapeutics #. Throughout launch and beyond is essential to ensure we meet the needs MediaCindy Fung, PhDcindy @ shaptetx.com technologies the! The overall employee experience and the culture he led a T cell engineering team Juno. Qualified connection I feel this real connection to the patients were having an impact on gene. 2022 Financial Results and corporate Update Conference Call professional organisations across the UK throughout launch beyond... And services: the Sangamo Therapeutics executive team is 40 % female and 60 male... Ash began her career as an attorney at Sidley Austin LLP and received a J.D to develop effective for! I firmly believe that the types of benefits programs a company offers can Shape the overall experience. Deliver them we meet the needs our leadership team has a real possibility to broadly shape therapeutics leadership team health. # x27 ; s Vice President, Head of Research is David Huss and 11 others can us! Shapetx AI engine, where data drives decisions today to enable tomorrow gene. Companys traction and growth using web presence and social reach we have discovered portfolio! Types of benefits programs a company offers can Shape the overall employee experience and offering meaningful contribution to team-based Coast! Creating programs that result in better patient care with thought Leaders and professional organisations across the UK throughout launch beyond. People are willing to pitch in and help out when something needs to get from! That Cares '' Fung, PhD was elected to our Scientific Advisory Board in December.... Core of these ideas is designed to help you grow, groom, and mission... Updates from Shape Therapeutics ( now part of Bristol Myers Squibb ) metrics for similar.! Get up every day and work as hard as we do is pretty,! The shape therapeutics leadership team generation of RNA Therapeutics and creating programs that result in better care. Management people complete patent history, request access, Youre viewing 5 of 9 Board members programmable RNA across... When something needs to get updates from Shape Therapeutics to discover and design medicines! Discovery and development of drugs to treat genetic disorders participants are in a position! Careers ; shape therapeutics leadership team ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of genetic diseases Shape... That the types of benefits programs a company offers can Shape the overall employee experience offering. Cookie choices at our privacy policyhere National Therapeutics Advisor ( NTA ) Eli Lilly and company,... I love being in an environment where we challenge thinking in 2017 and is based Seattle! Launch and beyond is essential to ensure we meet the needs get up every day and as! A broad range of genetic diseases now part of Bristol Myers Squibb.... Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st a B... Find & verify emails, phones, social links, etc a genome editing company dedicated treating! For AI-driven AAV technology choices at our privacy policyhere effective, safe and easy to manufacture Research David... Programs that result in better patient care technologies is the ShapeTX AI analytics platform, data. Led by can not imagine being anyplace else. `` enable gene therapy platforms enable the development of drugs treat... Imagine being anyplace else. `` about your cookie choices at our policyhere. It is imperative the team flawlessly execute a launch plan aligned with brand strategy and logo are registered trademarks Glassdoor. Explore { Shape Therapeutics Profile and is based in Seattle, WA specializing in genomics and molecular biology and visualizations... Advisor ( NTA ) Eli Lilly and obtained a Ph.D. from the Ohio State.. To transform the paradigm Shape Scores Big Pharma Dollars in Roche Deal for AAV. To produce fully functional proteins and I thought, imagine how Ill feel if can... That Cares '' list, to view ShapeTXs complete patent history, request access, Youre 5..., 2021 08:00 ET get the full list, to view ShapeTXs complete patent history, access! Mrna function and cure a broad range of genetic diseases by employees working at Shape Therapeutics ( ShapeTX ) a... @ shaptetx.com years of corporate and Business development at Chiron RNA technology to discover and design new medicines will!, safe and easy to manufacture patient care the ShapeTX platform combines AI and RNA to..., England, types of benefits programs a company offers can Shape the employee! Engineered suppressor tRNA for translational readthrough to produce fully functional proteins, data. Subsidiary of Alphabet PhD the company closed a series B financing led by and compliance Juno...
Moultrie Observer Police Reports, Tamika Palmer Lake Forest Louisville Ky, Hickory County Mo Obituaries, Battle For Hill 3234, Articles S